🇺🇸 FDA
Patent

US 10301314

Compounds and methods for the prevention and treatment of tumor metastasis and tumorigenesis

granted A61KA61K31/519A61K31/695

Quick answer

US patent 10301314 (Compounds and methods for the prevention and treatment of tumor metastasis and tumorigenesis) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue May 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/519, A61K31/695, A61K45/06, A61P